Molecular Templates, Inc.
MTEMDelisted May 22, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001183765
Molecular Templates, Inc. was delisted on May 22, 2025; its insiders filed their last Form 4 on Nov 18, 2024; no institution reported holding it in 13F filings for Q1 2025; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q1 2025, −3 vs. previous quarter
- 13F value
- $0
- Reported value at the end of Q1 2025
- Superinvestors holding
- 0
- At the end of Q1 2025
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2023
- –
- No comparable prior period
- Net income, FY2023
- -$8.12M
- No comparable prior period
- Free cash flow, FY2023
- -$42.0M
- No comparable prior period
- Revenue, Q2 FY2024
- –
- No comparable prior period
Superinvestors holding MTEM, Q1 2025
Go to the superinvestors tabNo superinvestor reported holding MTEM at the end of Q1 2025.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Molecular Templates, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 (view filing)9:12 PM ET | Nov 14 | 4 days | BB Biotech AG and 1 other10% Owner | SSale | −1.28M | $0.6609 | −$845.8K | −100.0%0 after | |
| Nov 18, 2024 (view filing)9:12 PM ET | Apr 2 | 230 daysLate | BB Biotech AG and 1 other10% Owner | PPurchase | +904.0K | $0.4563 | +$412.5K | –769.3K after | Derivative2 lotsDuplicate filing |
| Apr 4, 2024 (view filing)8:13 PM ET | Apr 2 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +250.0K | $2.35 | +$587.5K | +24.3%1.28M after | |
| Apr 4, 2024 (view filing)8:13 PM ET | Apr 2 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +904.0K | $0.4563 | +$412.5K | –769.3K after | Derivative2 lots |
| Jul 19, 2023 (view filing)3:14 PM ET | Jul 17 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +4.26M | $0.47 | +$2.00M | +38.0%15.4M after | |
| Jun 21, 2022 (view filing)5:09 PM ET | Jun 13-15 | 8 daysLate | French Douglas D and 6 others10% Owner | PPurchase | +222.0K | $0.8936 | +$198.4K | New position222.0K after | 3 lotsDuplicate filing |
| Jun 21, 2022 (view filing) | Jun 13-15 | 8 daysLate | Lalande Kevin M.Director, 10% Owner | PPurchase | +222.0K | $0.8936 | +$198.4K | New position222.0K after | 3 lots |
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | McLennan SeanSee remarks | PPurchase | +30.0K | $0.82 | +$24.6K | New position30.0K after | |
| May 18, 2022 (view filing)12:21 PM ET | May 16 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +200.0K | $1.18 | +$236.2K | +1.8%11.2M after | |
| Jan 10, 2022 (view filing)11:49 AM ET | Jan 6 | 4 days | BB Biotech AG and 1 other10% Owner | PPurchase | +200.0K | $4.04 | +$807.2K | +1.9%11.0M after |
Top 10 13F holders, Q1 2025
View all: Top 10 13F holders, Q1 2025The largest institutional positions in Molecular Templates, Inc. at the end of Q1 2025; share changes are against Q4 2024.
No institution reported holding MTEM in 13F filings for Q1 2025.